The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit
Abstract
Kit is a receptor tyrosine kinase (RTK) that binds stem cell factor. This receptor ligand combination is important for normal hematopoiesis, as well as pigmentation, gut function, and reproduction. Structurally, Kit has both an extracellular and intracellular region. Theintra-cellular region is comprised of a juxtamembrane domain (JMD), a kinase domain, a kinase insert, and a carboxyl tail. Inappropriate expression or activation of Kit is associated with a variety of diseases in humans. Activating mutations in Kit have been identified primarily in the JMD and the second part of the kinase domain and have been associated with gastrointestinal stromal cell tumors and mastocytosis, respectively. There are also reports of activating mutations in some forms of germ cell tumors and core binding factor leukemias. Since the cloning of the Kit ligand in the early 1990s, there has been an explosion of information relating to the mechanism of action of normal forms of Kit as well as activated mutants. This is important because understanding this RTK at the biochemical level could assist in the development of therapeutics to treat primary and secondary defects in the tissues that require Kit. Furthermore, understanding the mechanisms mediating transformation of cells by activated Kit mutants will help in the design of interventions for human disease associated with these mutations. The objective of this review is to summarize what is known about normal and oncogenic forms of Kit. We will place particular emphasis on recent developments in understanding the mechanisms of action of normal and activated forms of this RTK and its association with human disease, particularly in hematopoietic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., & Ullrich, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02655.x · Cited by 1,574
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
Geissler, E. N., Ryan, M. A., & Housman, D. E. (1988) · Cell · doi:10.1016/0092-8674(88)90020-7 · Cited by 1,287
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T., & Liu, Y.-C. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,034
The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
Chabot, B., Stephenson, D. A., Chapman, V. M., Besmer, P., & Bernstein, A. (1988) · Nature · doi:10.1038/335088a0 · Cited by 994
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin, B. P., Singer, S., Tsao, C., Duensing, A. U., Lux, M. L., Ruiz, R., Hibbard, M. K., Chen, C. J., Xiao, S., Tuveson, D. A., et al. (2001) · PubMed · Cited by 959
Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations
Weissman, I. L., Anderson, D. J., & Gage, F. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.387 · Cited by 948
Identification of a ligand for the c-kit proto-oncogene
Williams, D. E., Eisenman, J., Baird, A., Rauch, C., Van Ness, K., March, C. J., Park, L. S., Martin, U., Mochizukl, D. Y., Boswell, H. S., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90297-r · Cited by 911
Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
O'Farrell, A.-M., Abrams, T. J., Yuen, H. A., Ngai, T. J., Louie, S. G., Yee, K. W. H., Wong, L. M., Hong, W., Lee, L. B., Town, A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2307 · Cited by 864
Stem Cell Factor and Hematopoiesis
Broudy, V. C. (1997) · Blood · doi:10.1182/blood.v90.4.1345 · Cited by 858
Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116761 · Cited by 816
Cochet, C., Gill, G. N., Meisenhelder, J., Cooper, J. A., & Hunter, T. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43389-8 · Cited by 711
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Lyman, S. D., & Jacobsen, S. E. W. (1998) · Blood · doi:10.1182/blood.v91.4.1101 · Cited by 696
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Clinical management of gastrointestinal stromal tumors: Before and after STI-571
Dematteo, R. P., Heinrich, M. C., El-Rifai, W. M., & Demetri, G. (2002) · Human Pathology · doi:10.1053/hupa.2002.124122 · Cited by 637
Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase
Mol, C. D., Dougan, D. R., Schneider, T. R., Skene, R. J., Kraus, M. L., Scheibe, D. N., Snell, G. P., Zou, H., Sang, B.-C., & Wilson, K. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403319200 · Cited by 635
Heinrich, M. C., Blanke, C. D., Druker, B. J., & Corless, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1692 · Cited by 634
Besmer, P., Murphy, J. E., George, P. C., Qiu, F., Bergold, P. J., Lederman, L., Snyder, H. W., Brodeur, D., Zuckerman, E. E., & Hardy, W. D. (1986) · Nature · doi:10.1038/320415a0 · Cited by 629
Copeland, N. G., Gilbert, D. J., Cho, B. C., Donovan, P. J., Jenkins, N. A., Cosman, D., Anderson, D., Lyman, S. D., & Williams, D. E. (1990) · Cell · doi:10.1016/0092-8674(90)90298-s · Cited by 610
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
Kitamura, Y., Go, S., & Hatanaka, K. (1978) · Blood · doi:10.1182/blood.v52.2.447.447 · Cited by 608
Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y.-S., Langley, K., Ding, T.-G., Duffy, T., Jacobs, P., Tang, L. H., & Modlin, I. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 607
Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas, M. L., & Beier, D. R. (1993) · Cell · doi:10.1016/0092-8674(93)90369-2 · Cited by 581
The biology of stem cell factor and its receptor C-kit
Ashman, L. K. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00076-x · Cited by 576
Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G., & Humphries, R. K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1610 · Cited by 556
Longley, B. J., Metcalfe, D. D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.-Z., Heitjan, D., & Ma, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1609 · Cited by 552
Majka, M., Janowska-Wieczorek, A., Ratajczak, J., Ehrenman, K., Pietrzkowski, Z., Kowalska, M. A., Gewirtz, A. M., Emerson, S. G., & Ratajczak, M. Z. (2001) · Blood · doi:10.1182/blood.v97.10.3075 · Cited by 508
Ma, P. C., Kijima, T., Maulik, G., Fox, E. A., Sattler, M., Griffin, J. D., Johnson, B. E., & Salgia, R. (2003) · PubMed · Cited by 454
Ma, Y., Zeng, S., Metcalfe, D. D., Akin, C., Dimitrijevic, S., Butterfield, J. H., McMahon, G., & Longley, B. J. (2002) · Blood · doi:10.1182/blood.v99.5.1741 · Cited by 449
Effect of c-kit Mutation on Prognosis of Gastrointestinal Stromal Tumors
谷口, 正. (2001) · Cited by 438
Activating c-kit Gene Mutations in Human Germ Cell Tumors
Tian, Q., Frierson, H. F., Krystal, G. W., & Moskaluk, C. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65419-3 · Cited by 408
Early signaling pathways activated by c-Kit in hematopoietic cells
Linnekin, D. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00078-3 · Cited by 385
Self-citationAn essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development
Saba‐El‐Leil, M. K., Vella, F. D. J., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S., & Meloche, S. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor939 · Cited by 366
Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R., Stillman, B., & Clarkson, B. (1997) · Cell · doi:10.1016/s0092-8674(00)81840-1 · Cited by 362
Kissel, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1312 · Cited by 358
Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi, M., Nishida, T., Hirota, S., Isozaki, K., Ito, T., Nomura, T., Matsuda, H., & Kitamura, Y. (1999) · PubMed · Cited by 356
Blume-Jensen, P., Janknecht, R., & Hunter, T. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70302-1 · Cited by 356
Wybenga-Groot, L. E., Baskin, B., Ong, S. H., Tong, J., Pawson, T., & Sicheri, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00496-2 · Cited by 338
Blume-Jensen, P., Claesson-Welsh, L., Siegbahn, A., Zsebo, K. M., Westermark, B., & Heldin, C. H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04989.x · Cited by 330
Longley, B. J., Reguera, M. J., & Ma, Y. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00028-5 · Cited by 324
Huang, E. J., Nocka, K. H., Buck, J., & Besmer, P. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.3.349 · Cited by 316
Blume-Jensen, P., Jiang, G., Hyman, R., Lee, K.-F., O'Gorman, S., & Hunter, T. (2000) · Nature Genetics · doi:10.1038/72814 · Cited by 315
C-kit mutations in core binding factor leukemias
Beghini, A., Peterlongo, P., Ripamonti, C. B., Larizza, L., Cairoli, R., Morra, E., & Mecucci, C. (2000) · Blood · doi:10.1182/blood.v95.2.726 · Cited by 299
Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains.
Brannan, C. I., Lyman, S. D., Williams, D. E., Eisenman, J., Anderson, D. M., Cosman, D., Bedell, M. A., Jenkins, N. A., & Copeland, N. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4671 · Cited by 297
Interaction of the erythropoietin and stem-cell-factor receptors
Wu, H., Klingmüller, U., Besmer, P., & Lodish, H. F. (1995) · Nature · doi:10.1038/377242a0 · Cited by 295
In Vitro Self-Renewal Division of Hematopoietic Stem Cells
Ema, H., Takano, H., Sudo, K., & Nakauchi, H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1281 · Cited by 286
Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells
Ikeda, H., Kanakura, Y., Tamaki, T., Kuriu, A., Kitayama, H., Ishikawa, J., Kanayama, Y., Yonezawa, T., Tarui, S., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2962.2962 · Cited by 280
Structure of a c-Kit Product Complex Reveals the Basis for Kinase Transactivation
Mol, C. D., Lim, K. B., Sridhar, V., Zou, H., Chien, E. Y. T., Sang, B.-C., Nowakowski, J., Kassel, D. B., Cronin, C. N., & McRee, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300186200 · Cited by 274
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
Krystal, G. W., Honsawek, S., Litz, J., & Buchdunger, E. (2000) · PubMed · Cited by 265
Timokhina, I., Kissel, H., Stella, G., & Besmer, P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6250 · Cited by 265
Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis
Longley, B. J., Morganroth, G. S., Tyrrell, L., Ding, T. G., Anderson, D. M., Williams, D. E., & Halaban, R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281803 · Cited by 264
c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia
Gari, M., Goodeve, A., Wilson, G., Winship, P., Langabeer, S., Linch, D., Vandenberghe, E., Peake, I., & Reilly, J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01449.x · Cited by 262
Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.
Reith, A. D., Ellis, C., Lyman, S. D., Anderson, D. M., Williams, D. E., Bernstein, A., & Pawson, T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07784.x · Cited by 257
Huang, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4358 · Cited by 257
Irani, A., Nilsson, G., Miettinen, U., Craig, S., Ashman, L., Ishizaka, T., Zsebo, K., & Schwartz, L. (1992) · Blood · doi:10.1182/blood.v80.12.3009.3009 · Cited by 255
Miyazawa, K., Williams, D., Gotoh, A., Nishimaki, J., Broxmeyer, H., & Toyama, K. (1995) · Blood · doi:10.1182/blood.v85.3.641.bloodjournal853641 · Cited by 254
Juvenile Myelomonocytic Leukemia
Aricò, M., Biondi, A., & Pui, C.-H. (1997) · Blood · doi:10.1182/blood.v90.2.479 · Cited by 250
Frost, M. J., Ferrao, P. T., Hughes, T. P., & Ashman, L. K. (2002) · PubMed · Cited by 249
Sommer, G., Agosti, V., Ehlers, I., Rossi, F., Corbacioglu, S., Farkas, J., Moore, M., Manova, K., Antonescu, C. R., & Besmer, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037763100 · Cited by 244
Nishida, K., Yoshida, Y., Itoh, M., Fukada, T., Ohtani, T., Shirogane, T., Atsumi, T., Takahashi-Tezuka, M., Ishihara, K., Hibi, M., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1809.406k35_1809_1816 · Cited by 239
Wang, W.-L., Healy, M. E., Sattler, M., Verma, S., Lin, J., Maulik, G., Stiles, C. D., Griffin, J. D., Johnson, B. E., & Salgia, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203698 · Cited by 234
Kitayama, H., Kanakura, Y., Furitsu, T., Tsujimura, T., Oritani, K., Ikeda, H., Sugahara, H., Mitsui, H., Kanayama, Y., & Kitamura, Y. (1995) · Blood · doi:10.1182/blood.v85.3.790.bloodjournal853790 · Cited by 233
Cutler, R. L., Liu, L., Damen, J. E., & Krystal, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80558-4 · Cited by 229
Serve, H., Yee, N. S., Stella, G., Sepp-Lorenzino, L., Tan, J. C., & Besmer, P. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07023.x · Cited by 228
Papayannopoulou, T., Priestley, G. V., & Nakamoto, B. (1998) · Blood · doi:10.1182/blood.v91.7.2231 · Cited by 224
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
Shah, N. P., & Sawyers, C. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206942 · Cited by 216
Lennartsson, J., Blume-Jensen, P., Hermanson, M., Pontén, E., Carlberg, M., & Rönnstrand, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202929 · Cited by 208
Self-citationKozlowski, M., Larose, L., Lee, F., Le, D. M., Rottapel, R., & Siminovitch, K. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2089 · Cited by 204
Giles, F. J., Stopeck, A. T., Silverman, L. R., Lancet, J. E., Cooper, M. A., Hannah, A. L., Cherrington, J. M., O'Farrell, A.-M., Yuen, H. A., Louie, S. G., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3023 · Cited by 200
Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation
Sepulveda, P. D., Okkenhaug, K., Rose, J. L., Hawley, R. G., Dubreuil, P., & Rottapel, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.904 · Cited by 199
Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice
Fukao, T., Yamada, T., Tanabe, M., Terauchi, Y., Ota, T., Takayama, T., Asano, T., Takeuchi, T., Kadowaki, T., Hata, J.-I., et al. (2002) · Nature Immunology · doi:10.1038/ni768 · Cited by 193
Borge, O. J., Ramsfjell, V., Cui, L., & Jacobsen, S. E. W. (1997) · Blood · doi:10.1182/blood.v90.6.2282 · Cited by 193
Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow
Ashman, L., Cambareri, A., To, L., Levinsky, R., & Juttner, C. (1991) · Blood · doi:10.1182/blood.v78.1.30.30 · Cited by 188
Papayannopoulou, T., Brice, M., Broudy, V., & Zsebo, K. (1991) · Blood · doi:10.1182/blood.v78.6.1403.1403 · Cited by 183
Viable c-KitW/W Mutants Reveal Pivotal Role for c-Kit in the Maintenance of Lymphopoiesis
Waskow, C., Paul, S., Haller, C., Gassmann, M., & Rodewald, H.-R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00386-2 · Cited by 182
Liu, L., Damen, J. E., Cutler, R. L., & Krystal, G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6926 · Cited by 181
Yamanashi, Y., Tamura, T., Kanamori, T., Yamane, H., Nariuchi, H., Yamamoto, T., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.1.11 · Cited by 181
Linnekin, D., DeBerry, C. S., & Mou, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27450 · Cited by 161
Self-citationAutoinhibition of the Kit Receptor Tyrosine Kinase by the Cytosolic Juxtamembrane Region
Chan, P. M., Ilangumaran, S., La Rose, J., Chakrabartty, A., & Rottapel, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3067-3078.2003 · Cited by 161
Piao, X., Paulson, R., van der Geer, P., Pawson, T., & Bernstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14665 · Cited by 160
Paulson, R. F., Vesely, S., Siminovitch, K. A., & Bernstein, A. (1996) · Nature Genetics · doi:10.1038/ng0796-309 · Cited by 159
Sui, X., Krantz, S. B., You, M., & Zhao, Z. (1998) · Blood · doi:10.1182/blood.v92.4.1142 · Cited by 158
Yee, N. S., Hsiau, C. W., Serve, H. L., Vosseller, K., & Besmer, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31793-9 · Cited by 158
Blechman, J. M., Lev, S., Barg, J., Eisenstein, M., Vaks, B., Vogel, Z., Givol, D., & Yarden, Y. (1995) · Cell · doi:10.1016/0092-8674(95)90455-7 · Cited by 156
Zhang, Y.-Y., Vik, T. A., Ryder, J. W., Srour, E. F., Jacks, T., Shannon, K., & Wade Clapp, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1893 · Cited by 150
Regulation of phospholipase C γ isoforms in haematopoietic cells
Wilde, J. I., & Watson, S. P. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00191-7 · Cited by 149
Huang, S., Luca, M., Gutman, M., et al. (1996) · PubMed · Cited by 149
Chian, R., Young, S. M., Danilkovitch‐Miagkova, A., Rönnstrand, L., Leonard, E. J., Ferrao, P., Ashman, L. K., & Linnekin, D. (2001) · Blood · doi:10.1182/blood.v98.5.1365 · Cited by 149
Self-citationServe, H. L., Hsu, Y. C., & Besmer, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37564-6 · Cited by 148
Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.
Nishida, K., Wang, L., Morii, E., Park, S. J., Narimatsu, M., Itoh, S., Yamasaki, S., Fujishima, M., Ishihara, K., Hibi, M., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1866 · Cited by 148
Enhanced Hematopoiesis by Hematopoietic Progenitor Cells Lacking Intracellular Adaptor Protein, Lnk
Τακακι, S., Morita, H., Tezuka, Y., & Takatsu, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011170 · Cited by 147
The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells.
Tauchi, T., Feng, G., Marshall, M. S., Shen, R., Mantel, C., Pawson, T. J., & Broxmeyer, H. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31518-1 · Cited by 145
Miguel, M. P. D., Cheng, L., Holland, E. C., Federspiel, M. J., & Donovan, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249399 · Cited by 145
Ning, Z.-Q., Li, J., & Arceci, R. J. (2001) · Blood · doi:10.1182/blood.v97.11.3559 · Cited by 144
Targeted disruption of SHIP leads to Steel factor‐induced degranulation of mast cells
Huber, M., Helgason, C. D., Scheid, M. P., Duronio, V., Humphries, R. K., & Krystal, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7311 · Cited by 141
Yee, N. S., Langen, H., & Besmer, P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85226-2 · Cited by 137
Zhang, Z., Zhang, R., Joachimiak, A., Schlessinger, J., & Kong, X. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7732 · Cited by 137
Kitayama, H., Tsujimura, T., Matsumura, I., Oritani, K., Ikeda, H., Ishikawa, J., Okabe, M., Suzuki, M., Yamamura, K., Matsuzawa, Y., et al. (1996) · Blood · doi:10.1182/blood.v88.3.995.995 · Cited by 135
Li, C., & Johnson, G. (1994) · Blood · doi:10.1182/blood.v84.2.408.408 · Cited by 134
Keller, J. R., Ortiz, M., & Ruscetti, F. (1995) · Blood · doi:10.1182/blood.v86.5.1757.bloodjournal8651757 · Cited by 130
Ma, Y., Cunningham, M. E., Wang, X., Ghosh, I., Regan, L., & Longley, B. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13399 · Cited by 129
Tauchi, T., Boswell, H. S., Leibowitz, D. S., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.167 · Cited by 129
Role of the KIT protooncogene in normal and malignant human hematopoiesis.
Ratajczak, M. Z., Luger, S. M., DeRiel, K., Abrahm, J. L., Calabretta, B., & Gewirtz, A. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1710 · Cited by 128
Yokouchi, M., Suzuki, R., Masuhara, M., Komiya, S., Inoue, A., & Yoshimura, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201163 · Cited by 128
Kit Receptor Dimerization Is Driven by Bivalent Binding of Stem Cell Factor
Lemmon, M. A., Pinchasi, D., Zhou, M., Lax, I., & Schlessinger, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6311 · Cited by 126
Thömmes, K., Lennartsson, J., Carlberg, M., & Rönnstrand, L. (1999) · Biochemical Journal · doi:10.1042/bj3410211 · Cited by 126
Self-citationMolecular Basis of Human Piebaldism
Spritz, R. A. (1994) · Journal of Investigative Dermatology · doi:10.1038/jid.1994.25 · Cited by 125
Liao, A. T., Chien, M. B., Shenoy, N. R., Mendel, D. B., McMahon, G., Cherrington, J. M., & London, C. A. (2002) · Blood · doi:10.1182/blood-2001-12-0350 · Cited by 124
Alai, M., Mui, A., Cutler, R. L., Bustelo, X. R., Barbacid, M., & Krystal, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37146-7 · Cited by 122
Purification and characterization of bovine brain type I phosphatidylinositol kinase
Morgan, S. J., Smith, A. D., & Parker, P. J. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19185.x · Cited by 122
Weiler, S., Mou, S. M., DeBerry, C. S., Keller, J., Ruscetti, F., Ferris, D. K., Longo, D., & Linnekin, D. (1996) · Blood · doi:10.1182/blood.v87.9.3688.bloodjournal8793688 · Cited by 122
Self-citationSattler, M., Salgia, R., Shrikhande, G., Verma, S., Pisick, E. P., Prasad, K. V. S., & Griffin, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10248 · Cited by 120
Blume‐Jensen, P., Siegbahn, A., Stabel, S., Heldin, C., & Rönnstrand, L. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06104.x · Cited by 119
Radioprotection of mice by recombinant rat stem cell factor.
Zsebo, K. M., Smith, K. A., Hartley, C. A., Greenblatt, M., Cooke, K. R., Rich, W., & McNiece, I. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9464 · Cited by 118
Miyazawa, K., Toyama, K., Gotoh, A., Hendrie, P. C., Mantel, C., & Broxmeyer, H. (1994) · Blood · doi:10.1182/blood.v83.1.137.137 · Cited by 118
Protein tyrosine kinases in malignant melanoma
Easty, D. J., & Bennett, D. C. (2000) · Melanoma Research · doi:10.1097/00008390-200010000-00001 · Cited by 117
Structure of the active core of human stem cell factor and analysis of binding to its receptor Kit
Jiang, X., Gurel, O., Mendiaz, E. A., Stearns, G. W., Clogston, C. L., Lu, H. S., Osslund, T. D., Syed, R. S., Langley, K. E., & Hendrickson, W. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3192 · Cited by 116
Ueda, S., Mizuki, M., Ikeda, H., Tsujimura, T., Matsumura, I., Nakano, K., Daino, H., Honda, Z., Sonoyama, J., Shibayama, H., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3342 · Cited by 115
Crosier, P., Ricciardi, S., Hall, L., Vitas, M. R., Clark, S., & Crosier, K. (1993) · Blood · doi:10.1182/blood.v82.4.1151.1151 · Cited by 115
Vosseller, K., Stella, G., Yee, N. S., & Besmer, P. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.5.909 · Cited by 114
Piao, X., & Bernstein, A. (1996) · Blood · doi:10.1182/blood.v87.8.3117.bloodjournal8783117 · Cited by 112
Stat1 associates with c-kit and is activated in response to stem cell factor
DeBerry, C. S., Mou, S. M., & Linnekin, D. (1997) · Biochemical Journal · doi:10.1042/bj3270073 · Cited by 112
Self-citationSOCS-1/JAB/SSI-1 Can Bind to and Suppress Tec Protein-tyrosine Kinase
Ohya, K., Kajigaya, S., Yamashita, Y., Miyazato, A., Hatake, K., Miura, Y., Ikeda, U., Shimada, K., Ozawa, K., & Mano, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27178 · Cited by 112
Liu, S. K., & McGlade, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202337 · Cited by 112
Grap Is a Novel SH3-SH2-SH3 Adaptor Protein That Couples Tyrosine Kinases to the Ras Pathway
Feng, G., Ouyang, Y.-B., Hu, D.-P., Shi, Z., Gentz, R., & Ni, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12129 · Cited by 111
Thömmes, K., Lennartsson, J., Carlberg, M., et al. (1999) · PubMed · Cited by 110
Self-citationO'Laughlin-Bunner, B., Radosevic, N., Taylor, M. L., Shivakrupa, DeBerry, C., Metcalfe, D. D., Zhou, M., Lowell, C., & Linnekin, D. (2001) · Blood · doi:10.1182/blood.v98.2.343 · Cited by 109
Self-citationBench to Bedside and Back Again: Personalizing Treatment for Patients with GIST
Godwin, A. K. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0709 · Cited by 109
Cristofano, A. D., Niki, M., Zhao, M., Karnell, F. G., Clarkson, B. D., Pear, W. S., Aelst, L. V., & Pandolfi, P. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.275 · Cited by 108
Broudy, V., Smith, F. O., Lin, N., Zsebo, K. M., Egrie, J. C., & Bernstein, I. D. (1992) · Blood · doi:10.1182/blood.v80.1.60.60 · Cited by 108
Brizzi, M. F., Zini, M. G., Aronica, M. G., Blechman, J., Yarden, Y., & Pegoraro, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31749-6 · Cited by 106
Blume‐Jensen, P., Wernstedt, C., Heldin, C., & Rönnstrand, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14192 · Cited by 106
Lorenz, U. M., Bergemann, A. D., Steinberg, H. N., Flanagan, J. G., Li, X., Galli, S. J., & Neel, B. G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1111 · Cited by 105
Stem Cell Factor Is Localized in, Released from, and Cleaved by Human Mast Cells
de Paulis, A., Minopoli, G., Arbustini, E., de Crescenzo, G., Piaz, F. D., Pucci, P., Russo, T., & Marone, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2799 · Cited by 104
c‐kit point mutation of extracellular domain in patients with myeloproliferative disorders
Nakata, Y., Kimura, A., Katoh, O., Kawaishi, K., Hyodo, H., Abe, K., Kuramoto, A., & Satow, Y. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05364.x · Cited by 104
Autocrine/Paracrine Mechanisms in Human Hematopoiesis
Janowska‐Wieczorek, A., Majka, M., Ratajczak, J., & Ratajczak, M. Z. (2001) · Stem Cells · doi:10.1634/stemcells.19-2-99 · Cited by 104
Role for the Adaptor Protein Grb10 in the Activation of Akt
Jahn, T., Seipel, P., Urschel, S., Peschel, C., & Duyster, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.979-991.2002 · Cited by 102
Tsujimura, T., Morimoto, M., Hashimoto, K., Moriyama, Y., Kitayama, H., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1996) · Blood · doi:10.1182/blood.v87.1.273.273 · Cited by 102
Mantel, C., Luo, Z., Canfield, J., Braun, S. E., Deng, C., & Broxmeyer, H. (1996) · Blood · doi:10.1182/blood.v88.10.3710.bloodjournal88103710 · Cited by 102
Caruana, G., Cambareri, A. C., & Ashman, L. K. (1999) · Oncogene · doi:10.1038/sj.onc.1202939 · Cited by 101
Miyazawa, K., Hendrie, P. C., Mantel, C., Wood, K., Ashman, L. K., & Broxmeyer, H. E. (1991) · PubMed · Cited by 101
van Dijk, T. B., van den Akker, E., Amelsvoort, M. P.-V., Mano, H., Löwenberg, B., & Lindern, M. V. (2000) · Blood · doi:10.1182/blood.v96.10.3406 · Cited by 100
Krystal, G. W., Honsawek, S., Kiewlich, D., Liang, C., Vasile, S., Sun, L., McMahon, G., & Lipson, K. E. (2001) · PubMed · Cited by 97
Hendrie, P. C., Miyazawa, K., Yang, Y., Langefeld, C. D., & Broxmeyer, H. E. (1991) · PubMed · Cited by 95
Src Family Kinases Are Involved in the Differential Signaling from Two Splice Forms of c-Kit
Voytyuk, O., Lennartsson, J., Mogi, A., Caruana, G., Courtneidge, S. A., Ashman, L. K., & Rönnstrand, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211726200 · Cited by 95
Self-citationSTAT Protein Recruitment and Activation in c-Kit Deletion Mutants
Brizzi, M. F., Dentelli, P., Rosso, A., Yarden, Y., & Pegoraro, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16965 · Cited by 92
Ware, M. F., Tice, D. A., Parsons, S. J., & Lauffenburger, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30185 · Cited by 90
Wineman, J., Nishikawa, S., & Müller‐Sieburg, C. E. (1993) · Blood · doi:10.1182/blood.v81.2.365.365 · Cited by 90
Kapur, R., Majumdar, M., Xiao, X., McAndrews-Hill, M., Schindler, K., & Williams, D. A. (1998) · Blood · doi:10.1182/blood.v91.3.879 · Cited by 90
Distinct Signaling from Stem Cell Factor and Erythropoietin in HCD57 Cells
Jacobs-Helber, S. M., Penta, K., Sun, Z., Lawson, A. E., & Sawyer, S. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6850 · Cited by 89
Core binding factor genes and human leukemia.
Hart, S., & Foroni, L. (2002) · PubMed · Cited by 88
Gotoh, A., Takahira, H., Mantel, C., Litz-Jackson, S., Boswell, H. S., & Broxmeyer, H. (1996) · Blood · doi:10.1182/blood.v88.1.138.138 · Cited by 88
A Novel Mechanism of Cooperation between c-Kit and Erythropoietin Receptor
Kapur, R., & Zhang, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007442200 · Cited by 85
STAT3 activation is required for Asp816 mutant c-Kit induced tumorigenicity
Ning, Z.-Q., Li, J., McGuinness, M., & Arceci, R. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204590 · Cited by 85
Agosti, V., Corbacioglu, S., Ehlers, I., Waskow, C., Sommer, G., Berrozpe, G., Kissel, H., Tucker, C. M., Manova, K., Moore, M. A. S., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031983 · Cited by 85
Yokouchi, M., Wakioka, T., Sakamoto, H., Yasukawa, H., Ohtsuka, S., Sasaki, A. T., Ohtsubo, M., Valius, M., Inoue, A., Komiya, S., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202326 · Cited by 84
Signaling via Src family kinases is required for normal internalization of the receptor c-Kit.
Broudy, V. C., Lin, N. L., Liles, W. C., Corey, S. J., O'Laughlin, B., Mou, S. M., & Linnekin, D. (1999) · Blood · doi:10.1182/blood.v94.6.1979 · Cited by 81
Self-citationGiles, F. J., Cooper, M. A., Silverman, L. R., et al. (2003) · Cancer · doi:10.1002/cncr.11315 · Cited by 81
Interspecies Molecular Chimeras of Kit Help Define the Binding Site of the Stem Cell Factor
Lev, S., Blechman, J., Nishikawa, S.-I., Givol, D., & Yarden, Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2224 · Cited by 80
Lu-Kuo, J. M., Fruman, D. A., Joyal, D. M., Cantley, L. C., & Katz, H. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.6022 · Cited by 79
Dorsey, J. F., Cunnick, J. M., Mane, S., & Wu, J. (2002) · Blood · doi:10.1182/blood.v99.4.1388 · Cited by 79
Tan, B. L., Yazicioglu, M. N., Ingram, D. A., McCarthy, J., Borneo, J., Williams, D. A., & Kapur, R. (2003) · Blood · doi:10.1182/blood-2002-08-2521 · Cited by 78
Gommerman, J. L., Sittaro, D., Klebasz, N. Z., Williams, D. A., & Berger, S. A. (2000) · Blood · doi:10.1182/blood.v96.12.3734 · Cited by 76
Biology of Gastrointestinal Stromal Tumors: KIT Mutations and Beyond
Duensing, A. U., Heinrich, M. C., Fletcher, C. D. �., & Fletcher, J. A. (2004) · Cancer Investigation · doi:10.1081/cnv-120027585 · Cited by 76
Signal transduction by several KIT juxtamembrane domain mutations
Castéran, N., Sepulveda, P. D., Beslu, N., Aoubala, M., Letard, S., Lecocq, E., Rottapel, R. K., & Dubreuil, P. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206587 · Cited by 74
Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells
Okumura, N., Tsuji, K., Ebihara, Y., Tanaka, I., Sawai, N., Koike, K., Komiyama, A., & Nakahata, T. (1996) · Blood · doi:10.1182/blood.v87.10.4100.bloodjournal87104100 · Cited by 72
Krystal, G. W., DeBerry, C. S., Linnekin, D., & Litz, J. (1998) · PubMed · Cited by 72
Self-citationPhilo, J. S., Wen, J., Wypych, J., Schwartz, M. G., Mendiaz, E. A., & Langley, K. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6895 · Cited by 72
Role of Aspartic Acid 814 in the Function and Expression of c-kit Receptor Tyrosine Kinase
Moriyama, Y., Tsujimura, T., Hashimoto, K., Morimoto, M., Kitayama, H., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3347 · Cited by 72
Imatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors
Chen, H., Isozaki, K., Kinoshita, K., Ohashi, A., Shinomura, Y., Matsuzawa, Y., Kitamura, Y., & Hirota, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11025 · Cited by 70
Kimura, Y., Jones, N., Klüppel, M., Hirashima, M., Tachibana, K., Cohn, J. B., Wrana, J. L., Pawson, T. J., & Bernstein, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305363101 · Cited by 69
Blechman, J., Lev, S., Brizzi, M. F., Leitner, O., Pegoraro, L., Givol, D., & Yarden, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53623-1 · Cited by 65
O'Farrell, A.-M., Ichihara, M., Mui, A. L.-F., et al. (1996) · Blood · doi:10.1182/blood.v87.9.3655.bloodjournal8793655 · Cited by 64
Hashimoto, K., Tsujimura, T., Moriyama, Y., Yamatodani, A., Kimura, M., Tohya, K., Morimoto, M., Kitayama, H., Kanakura, Y., & Kitamura, Y. (1996) · Europe PMC (PubMed Central) · Cited by 63
Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells.
Ryan, J. J., Huang, H., McReynolds, L. J., Shelburne, C. P., Hu‐Li, J., Huff, T. F., & Paul, W. E. (1997) · PubMed · Cited by 62
Jahn, T., Seipel, P., Coutinho, S., Urschel, S., Schwarz, K. B., Miething, C., Serve, H. L., Peschel, C., & Duyster, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205559 · Cited by 62
Hong, L., Munugalavadla, V., & Kapur, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1401-1410.2004 · Cited by 62
Analysis of c-kit Receptor Dimerization by Fluorescence Resonance Energy Transfer
Broudy, V. C., Lin, N. L., Bühring, H., Komatsu, N., & Kavanagh, T. J. (1998) · Blood · doi:10.1182/blood.v91.3.898 · Cited by 62
Tsujimura, T., Hashimoto, K., Kitayama, H., Ikeda, H., Sugahara, H., Matsumura, I., Kaisho, T., Terada, N., Kitamura, Y., & Kanakura, Y. (1999) · Blood · doi:10.1182/blood.v93.4.1319 · Cited by 61
Duarte, R. F., & Frank, D. A. (2000) · Blood · doi:10.1182/blood.v96.10.3422 · Cited by 59
Patrik, W., Lennartsson, J., Gottfridsson, E., Yoshimura, A., & Rönnstrand, L. (2003) · Biochemical Journal · doi:10.1042/bj20020716 · Cited by 59
Self-citationGab1 Is an Integrator of Cell Death versus Cell Survival Signals in Oxidative Stress
Holgado-Madruga, M., & Wong, A. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4471-4484.2003 · Cited by 59
Liang, X., Wisniewski, D. J., Strife, A., Shivakrupa, Clarkson, B. D., & Resh, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200277200 · Cited by 58
Kapur, R., Chandra, S., Cooper, R. J., McCarthy, J., & Williams, D. A. (2002) · Blood · doi:10.1182/blood.v100.4.1287.h81602001287_1287_1293 · Cited by 57
Hashimoto, K., Matsumura, I., Tsujimura, T., Kim, D., Ogihara, H., Ikeda, H., Ueda, S., Mizuki, M., Sugahara, H., Shibayama, H., et al. (2003) · Blood · doi:10.1182/blood-2002-01-0177 · Cited by 57
Maddens, S., Charruyer, A., Plo, I., Dubreuil, P. C., Berger, S. A., Salles, B., Laurent, G., & Jaffrézou, J. (2002) · Blood · doi:10.1182/blood.v100.4.1294.h81602001294_1294_1301 · Cited by 56
Duarte, R. F., & Frank, D. A. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026231 · Cited by 56
Stem Cell Factor: A Hemopoietic Cytokine with Important Targets in Asthma
Oliveira, S. H. P., & Lukacs, N. W. (2003) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010033483990 · Cited by 54
Miyazaki, R., Ogata, H., & Kobayashi, Y. (2001) · Annals of Hematology · doi:10.1007/s002770000285 · Cited by 53
Shivakrupa, R., Bernstein, A., Watring, N., & Linnekin, D. (2003) · PubMed · Cited by 53
Self-citation
Cited by
Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
Lennartsson, J., & Rönnstrand, L. (2012) · Physiological Reviews · doi:10.1152/physrev.00046.2011 · Cited by 825
Self-citationPaschka, P., Marcucci, G., Ruppert, A. S., Mrózek, K., Chen, H., Kittles, R. A., Vukosavljevic, T., Perrotti, D., Vardiman, J. W., Carroll, A. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9500 · Cited by 663
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2011) · Oncogene · doi:10.1038/onc.2010.566 · Cited by 473
The tyrosine kinase network regulating mast cell activation
Gilfillan, A. M., & Rivera, J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00742.x · Cited by 428
Development, Migration, and Survival of Mast Cells
Okayama, Y., & Kawakami, T. (2006) · Immunologic Research · doi:10.1385/ir:34:2:97 · Cited by 427
Metadata
- Authors
- Lennartsson, J., Jelacic, T., Linnekin, D., & Shivakrupa, R.
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01
- Volume
- 23
- Issue
- 1
- Pages
- 16-43
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2053690380
- Cited by
- 303
- References
- 236
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.